Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...

showing that a significantly higher percentage of PN patients using Opzelura experienced a ≥4-point improvement in the Worst-Itch Numeric Rating Scale (WI-NRS4) at Week 12 compared to the ...

Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a ...

demonstrating that significantly more PN patients who applied ruxolitinib cream 1.5% versus vehicle control achieved a ≥4-point improvement from baseline in Worst-Itch Numeric Rating Scale (WI ...

According to the presentation, all patients had a median disease duration of over 4 years and a mean Worst Itch Numerical Rating Scale (WI-NRS) score of 8.4. A higher proportion of ruxolitinib- vs.